Asahi Kasei offers microcrystalline cellulose (MCC) for pharmaceuticals and nutraceuticals, highly regarded for its quality and performance derived from innovative particle morphology, guaranteeing a nitrite level of 0.1ppm on CoA and opening a new plant in 2023 to meet growing demand. Its Finechem division offers high-quality APIs and excipients including Tranexamic Acid, Cytarabine and Lecithin, built on proprietary synthesis, production engineering and quality assurance capabilities.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen